Bo Fang

机构：Qingdao University, Affiliated Hospital of Qingdao University, First Hospital of China Medical University, China Medical University · ORCID：0000-0002-3901-5643

发表论文 24 篇 · 总被引 376 次 · h-index 12

代表论文

• Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury (2019 · Journal of Medicinal Chemistry · 被引 63)
• Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) (2019 · European Journal of Medicinal Chemistry · 被引 47)
• Inhibition of UBA5 Expression and Induction of Autophagy in Breast Cancer Cells by Usenamine A (2021 · Biomolecules · 被引 35)
• Design, Synthesis, and Structure–Activity Relationship Analysis of Thiazolo[3,2‐ a ]pyrimidine Derivatives with Anti‐inflammatory Activity in Acute Lung Injury (2017 · ChemMedChem · 被引 34)
• Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer (2024 · Journal of Translational Medicine · 被引 26)
• Design, synthesis, and structure–activity relationships of 2-benzylidene-1-indanone derivatives as anti-inflammatory agents for treatment of acute lung injury (2018 · Drug Design Development and Therapy · 被引 23)